Power Life Sciences Inc.
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Alzheimer's Disease patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Alzheimer's Disease patients.
Alzheimer Disease
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Official Title : | In Depth Observational Clinical Trial Assessing Experiences of Alzheimer's Disease Patients To Determine Trial Attributes Affecting Completion Rates For Specific Demographic Groups |
| Actual Study Start Date : | February 2024 |
| Estimated Primary Completion Date : | February 2025 |
| Estimated Study Completion Date : | February 2026 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 50 Years to 80 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.